Dynamic Contrast Enhanced Magnetic Resonance Imaging in Monitoring Bone Metastases in Breast Cancer Patients Receiving Bisphosphonates and Endocrine Therapy

Acta Radiologica

Volumn 45, Issue 1, 2004, Pages 71-74

  Montemurro, F ^a   Russo, F ^a   Martincich, L ^a   Cirillo, S ^a   Gatti, M ^a   Aglietta, M ^a   Regge, D ^a  

^a CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

Bisphosphonates; Bone metastases; Breast neoplasms; Endocrine therapy; MR imaging

Indexed keywords

BONE; COMPUTERIZED TOMOGRAPHY; IMAGE CODING; MAGNETIC RESONANCE IMAGING; RADIOLOGY; TUMORS; X RAYS;

BREAST CANCER; BREAST NEOPLASMS;

PATIENT TREATMENT;

ANASTROZOLE; BISPHOSPHONIC ACID DERIVATIVE; GOSERELIN; IMIDAZOLE DERIVATIVE; LETROZOLE; NITRILE; PAMIDRONIC ACID; TAMOXIFEN; TRIAZOLE DERIVATIVE; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE TUMOR; BREAST TUMOR; FEMALE; HUMAN; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PILOT STUDY; PROSPECTIVE STUDY;

ADULT; AGED; BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; GOSERELIN; HUMANS; IMIDAZOLES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NITRILES; PILOT PROJECTS; PROSPECTIVE STUDIES; TAMOXIFEN; TRIAZOLES;

EID: 1642315866     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841850410003374     Document Type: Article

References (9)

1. Brown AL, Middleton G, MacVicar AD, Husband JE. T1-weighted magnetic resonance imaging in breast cancer vertebral metastases: changes on treatment and correlation with response to therapy. Clin Radiol 1998;53:493-501.
2. Byun WM, Shin SO, Chang Y. et al. Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy. AJNR 2002;23:906-12.
3. Ciray I, Lindman H, Astrom KG, Bergh J, Ahlstrom K.H. Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging. Acta Radiol 2001;42:198-206.
4. Hawighorst H, Libicher M, Knopp MV, et al. Evaluation of angiogenesis and perfusion of bone marrow lesions: role of semiquantitative and quantitative dynamic MRI. J Magn Reson Imag 1999;10:286-94.
5. Hortobagyi GN. Novel approaches to the management of bone metastases in patients with breast cancer. Semin Oncol 2002;29:134-44.
6. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-10.
7. Shapeero LG, Vanel D. Imaging evaluation of the response of high-grade osteosarcoma and Ewing sarcoma to chemotherapy with emphasis on dynamic contrastenhanced magnetic resonance imaging. Semin Musculoskelet Radiol 2000;4:137-46.
8. Taylor JS, Reddick WE. Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI. Adv Drug Deliv Rev 2000; 41:91-110.
9. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imag 1999:10:903-7.